AU2002211690A1 - Altered hox and wnt7a expression in human lung cancer - Google Patents

Altered hox and wnt7a expression in human lung cancer

Info

Publication number
AU2002211690A1
AU2002211690A1 AU2002211690A AU1169002A AU2002211690A1 AU 2002211690 A1 AU2002211690 A1 AU 2002211690A1 AU 2002211690 A AU2002211690 A AU 2002211690A AU 1169002 A AU1169002 A AU 1169002A AU 2002211690 A1 AU2002211690 A1 AU 2002211690A1
Authority
AU
Australia
Prior art keywords
lung cancer
human lung
hox
altered
wnt7a expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002211690A
Inventor
Harry A. Drabkin
Robert M. Gemmill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Technology Corp
Original Assignee
University of Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Technology Corp filed Critical University of Technology Corp
Publication of AU2002211690A1 publication Critical patent/AU2002211690A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
AU2002211690A 2000-10-11 2001-10-11 Altered hox and wnt7a expression in human lung cancer Abandoned AU2002211690A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23959600P 2000-10-11 2000-10-11
US60239596 2000-10-11
PCT/US2001/031960 WO2002031210A1 (en) 2000-10-11 2001-10-11 Altered hox and wnt7a expression in human lung cancer

Publications (1)

Publication Number Publication Date
AU2002211690A1 true AU2002211690A1 (en) 2002-04-22

Family

ID=22902857

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211690A Abandoned AU2002211690A1 (en) 2000-10-11 2001-10-11 Altered hox and wnt7a expression in human lung cancer

Country Status (2)

Country Link
AU (1) AU2002211690A1 (en)
WO (1) WO2002031210A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713526B2 (en) 2001-05-01 2010-05-11 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
WO2002088081A2 (en) 2001-05-01 2002-11-07 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
CN106117355B (en) * 2016-06-30 2019-04-05 北京大学 A kind of specific antibody and preparation method thereof of transcription factor HOXB9 acetylation sites
CN106282347A (en) * 2016-08-17 2017-01-04 中南大学 HoxC11 as biomarker preparation adenocarcinoma of lung pre-diagnostic reagent in application
CN107041954A (en) * 2017-05-19 2017-08-15 镇江市第人民医院 Purposes of the HOXA1 in antineoplastic is prepared
CN110964812B (en) * 2018-09-29 2021-10-22 广州康立明生物科技股份有限公司 Application of HOXA9 methylation detection reagent in preparation of lung cancer diagnosis reagent
CN115785221B (en) * 2022-07-11 2023-07-04 北京大学 Specific antibody of transcription factor HOXB9 phosphorylation site, and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866404A (en) * 1995-12-06 1999-02-02 Yale University Yeast-bacteria shuttle vector
US6512102B1 (en) * 1998-12-31 2003-01-28 Chiron Corporation Compositions and methods of diagnosis and treatment using casein kinase I

Also Published As

Publication number Publication date
WO2002031210A1 (en) 2002-04-18
WO2002031210B1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001288432A1 (en) Materials and methods to potentiate cancer treatment
AU2002223296A1 (en) Modeling object interactions and facial expressions
AU2001296550A1 (en) Dermabrasion and skin care apparatus
AU2002215325A1 (en) Scalp cosmetic and dermatological compositions
AU2002243246A1 (en) Cddo-compounds and combination therapies thereof
AU2001290229A1 (en) Pyridazinones and triazinones and medicinal use thereof
AU2001233739A1 (en) Use of natural substances in the production of cosmetic preparations
AU2001248751A1 (en) Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU2002211717A1 (en) Stresscopins and their uses
AU4117000A (en) Cosmetic product and its use
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU7458201A (en) Laminate and use thereof
AU2002211690A1 (en) Altered hox and wnt7a expression in human lung cancer
AU2001252917A1 (en) 7 human ovarian and ovarian cancer associated proteins
AU2002361306A1 (en) Cosmetic composition that mimics sebum and the use thereof
AU2001261375A1 (en) Human caspase-12 materials and methods
GB0200204D0 (en) Cosmetic and related preparations
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU2002217984A1 (en) Erythropoietin and erythropoietin receptor expression in human cancer
AU2001276462A1 (en) Use of natural products in cancer treatment